Naveruclif
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Naveruclif, covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: EMA Authorised: Naveruclif (paclitaxel) — Accord Healthcare S.L.U.